Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Implications of Glycosylation in Alzheimer’s Disease

13 Jan 2021

Abstract excerpt

Alzheimer's disease (AD) is the most common cause of dementia, affecting millions of people worldwide, and no cure is currently available. The major pathological hallmarks of AD are considered to be amyloid beta plaques and neurofibrillary tangles, generated by respectively APP processing and Tau phosphorylation. Recent evidence imply that glycosylation of these proteins, and a number of other AD-related...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Glycosylation and Glycoproteins Research
Share to Lysosomal Storage Disorders Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33519371
DOI: 10.3389/fnins.2020.625348

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Implications of Glycosylation in Alzheimer’s DiseasePMID 33519371Read ↗

Early Stage Glycosylation Biomarkers in Alzheimer’s DiseaseSemantic proximity Read ↗

Dessert or Poison? The Roles of Glycosylation in Alzheimer's, Parkinson's, Huntington's Disease, and Amyotrophic Lateral SclerosisSemantic proximity Read ↗

Multilayered N-glycoproteomics reveals impaired N-glycosylation promoting Alzheimer’s diseaseSemantic proximity Read ↗

Serum N-Glycan Profiling Identifies Candidate Glycan Biomarkers for Early Detection and Prediction of Alzheimer’s DiseaseSemantic proximity Read ↗

Transcriptomic and glycomic analyses highlight pathway-specific glycosylation alterations unique to Alzheimer’s diseaseSemantic proximity Read ↗

Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease.Semantic proximity Read ↗

Integrative glycoproteomics reveals protein N-glycosylation aberrations and glycoproteomic network alterations in Alzheimer’s diseaseSemantic proximity Read ↗

Proteomics of Alzheimer's disease: Unveiling protein dysregulation in complex neuronal systems.Semantic proximity Read ↗

Unique N-glycosylation signatures in Aβ oligomer- and lipopolysaccharide-activated human iPSC-derived microgliaSemantic proximity Read ↗

Role of Post‐translational Modifications in Alzheimer's DiseaseSemantic proximity Read ↗

Amyloid ß<sub>1–42</sub> Peptide Induces Galectin-1<sup>S8</sup> O-GlcNAcylation to Lead Microglia MigrationSemantic proximity Read ↗

Human brain glycoform co-regulation network and glycan modification alterations in Alzheimer’s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.